136 related articles for article (PubMed ID: 38305574)
1. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?
Noda Y; Pisuchpen N; Parakh A; Srinivas-Rao S; Kinowaki Y; Mino-Kenudson M; Kambadakone AR
Br J Radiol; 2024 Feb; 97(1155):607-613. PubMed ID: 38305574
[TBL] [Abstract][Full Text] [Related]
2. Preoperative CT-based detection of extrapancreatic perineural invasion in pancreatic cancer.
Khristenko E; Shrainer I; Setdikova G; Palkina O; Sinitsyn V; Lyadov V
Sci Rep; 2021 Jan; 11(1):1800. PubMed ID: 33469112
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
[TBL] [Abstract][Full Text] [Related]
4. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
5. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
[TBL] [Abstract][Full Text] [Related]
6. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
Amer AM; Zaid M; Chaudhury B; Elganainy D; Lee Y; Wilke CT; Cloyd J; Wang H; Maitra A; Wolff RA; Varadhachary G; Overman MJ; Lee JE; Fleming JB; Tzeng CW; Katz MH; Holliday EB; Krishnan S; Minsky BD; Herman JM; Taniguchi CM; Das P; Crane CH; Le O; Bhosale P; Tamm EP; Koay EJ
Cancer; 2018 Apr; 124(8):1701-1709. PubMed ID: 29370450
[TBL] [Abstract][Full Text] [Related]
7. Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy.
Noda Y; Pisuchpen N; Mercaldo ND; Sekigami Y; Michelakos T; Parakh A; Wo JY; Qadan M; Ferrone C; Lillemoe KD; Ryan DP; Clark JW; Fernandez-Del Castillo C; Hong TS; Kambadakone AR
Eur Radiol; 2022 Apr; 32(4):2470-2480. PubMed ID: 34665317
[TBL] [Abstract][Full Text] [Related]
8. MRI vs. CT for pancreatic adenocarcinoma vascular invasion: comparative diagnostic test accuracy systematic review and meta-analysis.
Jajodia A; Wang A; Alabousi M; Wilks C; Kulkarni A; van der Pol CB
Eur Radiol; 2023 Oct; 33(10):6883-6891. PubMed ID: 37083741
[TBL] [Abstract][Full Text] [Related]
9. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
Park SJ; Kim JH; Joo I; Lee KB; Han JK
Eur Radiol; 2021 Jun; 31(6):3616-3626. PubMed ID: 33201279
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteria.
Yang HK; Park MS; Choi M; Shin J; Lee SS; Jeong WK; Hwang SH; Choi SH
Abdom Radiol (NY); 2021 Nov; 46(11):5201-5217. PubMed ID: 34331549
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
[No Abstract] [Full Text] [Related]
12. Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up CT.
Park SJ; Kim JH; Joo I; Han JK
Abdom Radiol (NY); 2021 Oct; 46(10):4765-4778. PubMed ID: 34085090
[TBL] [Abstract][Full Text] [Related]
13. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
14. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT.
Noda Y; Kawai N; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
Abdom Radiol (NY); 2022 Aug; 47(8):2835-2844. PubMed ID: 35760922
[TBL] [Abstract][Full Text] [Related]
15. Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performance.
Lee DH; Lee SS; Lee JM; Choi JY; Lee CH; Ha HI; Kang BK; Yu MH; Chang W; Park SJ
Cancer Imaging; 2023 Dec; 23(1):126. PubMed ID: 38111054
[TBL] [Abstract][Full Text] [Related]
16. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
[No Abstract] [Full Text] [Related]
17. Determination of arterial invasion in pancreatic ductal adenocarcinoma: what is the best diagnostic criterion on CT?
Noda Y; Mizuno N; Kawai N; Ando T; Kawaguchi M; Nagata S; Fujimoto K; Nakamura F; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
Eur Radiol; 2023 May; 33(5):3617-3626. PubMed ID: 36897348
[TBL] [Abstract][Full Text] [Related]
18. Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?
Clanton J; Oh S; Kaplan SJ; Johnson E; Ross A; Kozarek R; Alseidi A; Biehl T; Picozzi VJ; Helton WS; Coy D; Dorer R; Rocha FG
HPB (Oxford); 2018 Oct; 20(10):925-931. PubMed ID: 29753633
[TBL] [Abstract][Full Text] [Related]
19. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.
Park S; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Hong SB; Park SH
Eur Radiol; 2021 May; 31(5):3383-3393. PubMed ID: 33123793
[TBL] [Abstract][Full Text] [Related]
20. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
